Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial

por Tobback, Els, Degroote, Sophie, Buysse, Sabine, Delesie, Liesbeth, Van Dooren, Lucas, Vanherrewege, Sophie, Barbezange, Cyril, Hutse, Veronik, Romano, Marta, Thomas, Isabelle, Padalko, Elizaveta, Callens, Steven, De Scheerder, Marie-Angélique
Publicado 2022